Directorio
BENEDICTO CRESPO FACORRO
Categoría
Catedrático de Universidad (Pza. V.)
Contacto
Correo electrónico
Departamento
Área
Psiquiatría
Centro
Docencia
Asignaturas que imparte
Investigación
Grupo de investigación
Psiquiatría Traslacional (PsyNal)
Proyectos y contratos de investigación
SchizOMICS: Estudio multidisciplinar CIBER para optimizar el tratamiento de la esquizofrenia utilizando datos multi-omics y biología de sistemas (ICI21_00089 - Coordinador Work Package)
Clozapina para el tratamiento de psicosis en personas con discapacidad intelectual (ICI19_00026 - Investigador Principal Consolidado)
Sintonizando mundos: neurociencia para adolescentes (FCT-20-16227 - Investigador/a)
CIBER 2007 CRESPO FACORRO, BENEDICTO CB07/09/2001 G-B (00400200101834 - Investigador Principal Consolidado)
The role of ADAMTS2 in schizophrenia: New mechanistic insights into brain functioning and therapeutic perspectives based on mouse and cellular models (P20_00811 - Investigador Principal Consolidado)
CD19/00183 Contrato Sara Borrell (CD19/00183 - Investigador Principal Consolidado)
CM20/00015 Contrato Rio Hortega (CM20/00015 - Investigador Principal Consolidado)
Prevención del riesgo de suicidio en la era post-pandemia COVID-19: Integrando modelos clínicos personalizados y biológicos. (RH-0081-2020 - Investigador Principal Consolidado)
Prevención e Intervención en Suicidio (SURVIVE): estudio de cohorte y ensayos clínicos controlados anidados de programas de prevención secundaria para (PI19/000685 - Investigador/a)
ASESORAMIENTO EN PROTOCOLOS DE INVESTIGACION DE ENSAYOS CLINICOS EN EL AREA TERAPEUTICA DE ESQUIZOFRENIA (Investigador Principal Joven)
Guía de Psicoeducación para las Familias de Personas Diagnosticadas de Psicosis (FC-ESM 2008 - Investigador/a)
Guía para Médicos de Atención Primaria sobre Primeros Episodios de Psicosis (FC-ESM 2010 - Investigador/a)
Estudio de fase 2, aleatorizado, doble ciego, controlado con placebo, para evaluar el efecto de AMG 747, como tratamiento adicional, sobre los síntoma (2011-004844-23 - Investigador/a)
Estudio observacional de cohorte prospectiva de pacientes con síntomas persistentes de esquizofrenia para describir el curso y la carga de la enfermed (ROC-ESQ-2012-01 - Investigador/a)
Estudio observacional, MAP y de 6 semanas de seguimiento para evaluar la variación de la gravedad de la enfermedad en pacientes con esquizofrenia que (AN-PAL-2011-01 - Investigador/a)
ROAC2014. Estudio abierto randomizado de dosis flexibles de la efectividad de antipsicóticos de segunda generación en el tratamiento de pacientes con (2013-005399-16 - Investigador/a)
Estudio observacional para la evaluación del coste/efectividad de la intervención farmacogenética en la optimización del tratamiento con antipsicótico (RCC-ANT-2013-01 - Investigador/a)
EULAST - European Long-acting Antipsychotics in Schizophrenia Trial (Comparing outcome in schizophrenia between different depot antipsychotics and ora (2014-002765-30 - Investigador/a)
Proyecto de Cohortes Primeros Episodios de Psicosis (SAM16PE07 - Investigador/a)
Placebo-controlled trial in subjects at ultra-high risk for psychosis with omega-3 fatty acids in Europe (2015-003503-39 - Responsable)
A Study to Evaluate the Effect of ALKS 3831 Compared to Olanzapine on Body Weight in Young Adults with Schizophrenia, Schizophreniform, or Bipolar I D (NCT03187769 - Investigador/a)
Aripiprazole once-monthly versus daily oral atypical antipsychotic treatment in patients with recent-onset schizophrenia: an observational, non-interv (NCT03130465 - Investigador/a)
Cannabis y psicosis: estudio de marcadores genéticos y de factores clinicos y cognitivos pronosticos de discapacidad (SCO/3246/2004 - Responsable)
Ensayo clínico de prevención de recaídas en psicosis de inicio reciente: ensayo clínico aleatorizado HUMV/EPPIC (PI050697 - Responsable)
Estudio transversal y longitudinal de la accion de las citocinas en la regulacion de las proteinas de sinapsis en la esquizofrenia. Implicaciones y re (PI050427 - Responsable)
Genetics and Neuroimaging markers for schizophrenia (CI2005-0308007 - Responsable)
Efectos de los fármacos antipsicóticos en la morfometria cortical y subcortical cerebral en primeros episodios de esquizofrenia (PI060507 - Responsable)
Efectos de los fármacos antipsicóticos en la morfometria cortical y subcortical cerebral en primeros episodios de esquizofrenia (Exp.: API07/011). (Exp.: API07/011 - Responsable)
Identificación de un biomarcador asociado a células progenitoras neuronales mediante Espectroscopia de RM: Desarrollo de procesamiento de señales basa (PT79B - Responsable)
Identificación de marcadores moleculares en la esquizofrenia (FLTQ 2009) (FLTQ 2009 - Responsable)
Influencia de variaciones en genes implicados en el neurodesarrollo sobre las alteraciones estructurales cerebrales en primeros episodios de esquizofr (PI10/00183 - Responsable)
Caracterización de genes involucrados en la esquizofrenia mediante análisis de expresión génica y genómica poblacional (FLTQ-2010) (FLTQ-2010 - Responsable)
ROAMER - A Roadmap for Mental Health Research in Europe (HEALTH.2011.3.3-4_Grant agreement no. 282586 - Responsable)
Bases Biopsicosociales de las psicosis y predictors de la respuesta al tratamiento y del curso clínico (Trastornos emocionales y de conducta) (C03-C06 - Responsable)
Morfología Cortical Cerebral en la Esquizofrenia: Estudio transversal y longitudinal de pacientes en las primeras etapas de la enfermedad (PI020499 - Responsable)
Contrato de Intensificacion Investigadores del entorno Sevicio Cántabro de Salud (ISCIII-INT12/235 - Responsable)
ACI 07/03 (ARECES 2006) Investigación genómica en pacientes con un primer episodio de esquizofrenia: identificación de marcadores genéticos y farmacog (ACI 07/03 (ARECES 2006) - Responsable)
Contribución de las variaciones genéticas de nucleótido único (SNPs) en genes candidatos a la ganancia ponderal inducida por antipsicóticos (API 10/13 (API 10/13 - Responsable)
Perfiles de expresión génica y variantes genómicas asociadas con esquizofrenia -Gene expression profiles and genomic variants associated with schizoph (SAF2010-20840-C02-02 - Responsable)
MENTHELDER ¿ Preventing Mental Health-Related Problems In The Elderly (HORIZON 2020; Action group A3 - Action for prevention of functional decline and (- - Responsable)
Comorbilidad entre Enfermedades Neuropsiquiátricas y del Sistema Nervioso Central con el Cáncer (GIEX+COMNPC): Necesidades y Oportunidades para una in (PROMETEO/2011/042 - Responsable)
Red de Innovación en Tecnologías Médicas y Sanitarias (Red ITEMAS). (RD09/0077/00014 - - Responsable)
Red Temática de Investigación Cooperativa en Salud (RETICS) de Biobancos (RD09/0076/00076 - Responsable)
CONTRATO DE INTENSIFICACIÓN (- - Responsable)
EUSARNAD - Joint European and South African Research Network in Anxiety Disorders. Training in methods for epidemiological studies in anxiety disorder (FP7?PEOPLE?2010?IRSES_grant 269213 - Responsable)
CONTRATOS PARA LA INTENSIFICACIÓN DE LA ACTIVIDAD INVESTIGADORA EN EL SNS (ISCIII-INT13/00143 - Responsable)
GEXANT: Nuevos genes candidatos para la respuesta al tratamiento antipsicótico en esquizofrenia: evidencia desde estudios de expresión génica (SAF2013-46292-R - Responsable)
NUEVOS GENES CANDIDATOS PARA LA RESPUESTA AL TRATAMIENTO ANTIPSICÓTICO EN ESQUIZOFRENIA: EVIDENCIA DESDE ESTUDIOS DE EXPRESIÓN GÉNICA (- - Responsable)
Contrato de Intensificacion (ISCIII-INT15/00096 - Responsable)
PRISM Project: Precision medicine comes to Neurosymptomatics (115916 - PRISM Project - Investigador/a)
PLATAFORMA DE INNOVACIÓN EN TECNOLÓGIAS MÉDICAS Y SANITARIAS (- - Responsable)
PLATAFORMA DE BIOBANCOS (- - Responsable)
Contrato de Intensificacion INVESTIGADORES DEL ENTORNO SERVICIO CANTABRO DE SALUD CONV 2016 (- - Responsable)
Desarrollo cerebral y condiciones estresantes tempranas en salud mental: el rol mediador de mecanismos epigenéticos y correlatos de neuroimagen (SAF2015-71526-REDT - Investigador/a)
Solución tecnológica para la prevención de recaídas y la rehabilitación en esquizofrenia (INNVAL16/03 - Responsable)
Understanding Obesity (OB), Metabolic Syndrome (METS), Type 2 Diabetes (T2DM) and Fatty Liver Disease (FL): a multidisciplinary approach (PIE14/00031 - Responsable)
Contrato Predoctoral asociado al proyecto SAF2013-46292-R -Novel candidate genes for treatment response to antipsychotics in schizophrenia: Evidence f (BES-2014-070615 - Responsable)
Contratos Río Hortega de la convocatoria 2016- GRUPO CRESPO-FACORRO (CM16/00034 - Responsable)
Iniciativa de promoción a la investigación europea Valdecilla (VALER H2020) (ECT-2017-0371 - Responsable)
Personalized medicine in HCV infection: understanding and predicting hepatic and systemic responses in the era of the new antiviral drugs (PIE15/00079 - Responsable)
TRATAMIENTO ESTRATIFICADO EN ESQUIZOFRENIA: INTEGRANDO RESULTADOS DE TRANSCRIPTOMA HUMANO Y CELULAR EN LAS ESTRATEGIAS DE TRATAMIENTO ANTIPSICOTICO (SAF2016-76046-R - Responsable)
PLATAFORMA DE UNIDADES DE INVESTIGACIÓN CLÍNICA Y ENSAYOS CLÍNICOS (Scren) (PT17/0017/0039 - Responsable)
Grant agreement no. 603196 - PSYSCAN Translating neuroimaging findings from research into clinical practice (HEALTH.2013.2.2.1-2 - Responsable)
Atmospheric Electricity Network: coupling with the Earth System, climate and biological systems (ELECTRONET) (CA15211 - Investigador/a)
Mapping Heterogeneity of Neuroanatomical Imaging Signatures of Psychosis via Pattern Analysis (1R01MH112070-01A1 - Investigador/a)
PSYCH UP Improving support for people affected by psychological disorders (EU 18/08: VET - Responsable)
Glutamine Metabolism in the Brain Liver axis in NAFLD (UMBRELLA) (UMBRELLA - Responsable)
Enhancing Psychiatric Genetic Counselling, Testing, and Training in Europe (EnGagE) (CA17130 - Investigador/a)
El papel de ADAMTS2 en esquizofrenia: nuevos conocimientos sobre mecanismos cerebrales implicados y perspectivas terapéuticas basado en modelos animal (- - Responsable)
Artículos publicados
Velasco-barbancho, Elena;Rodenas-Luque, Gabriel;Perona-Garcelán, Salvador;Senín-calderón, Cristina;Rodríguez-Testal, Juan Francisco;Ruiz-Veguilla, Miguel;Crespo-facorro, Benedicto:
Dissociation as a Mediator of Traumatic Childhood Experiences and Ideas of Reference. Journal of Trauma & Dissociation. 2022. 10.1080/15299732.2022.2119632.
Dissociation as a Mediator of Traumatic Childhood Experiences and Ideas of Reference. Journal of Trauma & Dissociation. 2022. 10.1080/15299732.2022.2119632.
Ródenas-perea, Gabriel;Velasco-barbancho, Elena;Perona-Garcelán, Salvador;Rodríguez-Testal, Juan Francisco;Senín-calderón, Cristina;Crespo-facorro, Benedicto;Ruiz-Veguilla, Miguel:
Childhood and adolescent traumas and dissociation: the mediating role of rumination, intrusive thoughts and negative affect. Scandinavian Journal of Psychology. 2022. https://doi.org/10.1111/sjop.12879.
Childhood and adolescent traumas and dissociation: the mediating role of rumination, intrusive thoughts and negative affect. Scandinavian Journal of Psychology. 2022. https://doi.org/10.1111/sjop.12879.
Crespo-facorro, Benedicto;Ruiz-Veguilla, Miguel;Sánchez-Hidalgo, Ana C.;Cisneros-Herreros, José Miguel;Sainz-, Jesus:
Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Frontiers in Pharmacology. 2021. 10.3389/fphar.2021.646701.
Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Frontiers in Pharmacology. 2021. 10.3389/fphar.2021.646701.
Murillo-garcía, Nancy;Setién-suero, Esther;Pardo -de Santayana, Guillermo;Murillo-garcía, Marisol;Pelayo -terán, José María;Crespo-facorro, Benedicto;Ayesa-arriola, Rosa:
Entire duration of active psychosis and neurocognitive performance in first-episode non-affective psychosis. Early Intervention In Psychiatry. 2021. Vol: 15. Núm: 5. Pág. 1266-1275. 10.1111/eip.13077.
Entire duration of active psychosis and neurocognitive performance in first-episode non-affective psychosis. Early Intervention In Psychiatry. 2021. Vol: 15. Núm: 5. Pág. 1266-1275. 10.1111/eip.13077.
Rodríguez-pérez, Noelia;Ayesa-arriola, Rosa;Ortiz-garcía De La Foz, Víctor;Setién-suero, Esther;Tordesillas-gutiérrez, Diana;Crespo-facorro, Benedicto;Group Study, Pafip :
Long term cortical thickness changes after a first episode of non-affective psychosis: The 10 year follow-up of the PAFIP cohort. Progress in Nneuro-Psychopharmacology & Biological Psychiatry. 2021. Vol: 108. 10.1016/j.pnpbp.2020.110180.
Long term cortical thickness changes after a first episode of non-affective psychosis: The 10 year follow-up of the PAFIP cohort. Progress in Nneuro-Psychopharmacology & Biological Psychiatry. 2021. Vol: 108. 10.1016/j.pnpbp.2020.110180.
Izquierdo, Ana;Group Study, Pafip;Cabello, María ;De La Torre-luque, Alejandro;Ayesa-arriola, Rosa ;Setién-suero, Esther ;Mayoral-van Son, Jacqueline ;Vázquez-bourgon, Javier;Ayuso -mateos, José Luis;Crespo-facorro, Benedicto:
A network analysis approach to functioning problems in first psychotic episodes and their relationship with duration of untreated illness:Findings fro. Journal of Psychiatric Research. 2021. Vol: 136. Pág. 483-491. 10.1016/j.jpsychires.2020.10.019.
A network analysis approach to functioning problems in first psychotic episodes and their relationship with duration of untreated illness:Findings fro. Journal of Psychiatric Research. 2021. Vol: 136. Pág. 483-491. 10.1016/j.jpsychires.2020.10.019.
Vázquez-bourgon, Javier;Mayoral-van-son, Jacqueline;Gómez-revuelta, Marcos;Juncal-ruíz, María;Ortiz-garcía De La Foz, Víctor ;Tordesillas-gutiérrez, Diana ;Ayesa-arriola, Rosa ;Bioque, Miquel;Crespo-facorro, Benedicto:
Treatment discontinuation impact on long-term (10-years) weight gain andlipid metabolism in first-episode psychosis: results from the PAFIP-10 cohort.. International Journal of Neuropsychopharmacology. 2021. Vol: 24. Núm: 1. Pág. 1-7. 10.1093/ijnp/pyaa066.
Treatment discontinuation impact on long-term (10-years) weight gain andlipid metabolism in first-episode psychosis: results from the PAFIP-10 cohort.. International Journal of Neuropsychopharmacology. 2021. Vol: 24. Núm: 1. Pág. 1-7. 10.1093/ijnp/pyaa066.
Delgado-alvarado, Manuel;Vázquez-bourgon, Javier;Ayesa-arriola, Rosa;Ortiz-garcía De La Foz, Victor;Mayoral-van Son, Jacqueline;Labad, Javier;Crespo-facorro, Benedicto:
Predictive value of prolactin in first episode psychosis at ten years follow-up. Revista de Psiquiatría y Salud Mental. 2021. Vol: 14. Núm: 3. Pág. 179-180. 10.1016/j.rpsmen.2020.10.002.
Predictive value of prolactin in first episode psychosis at ten years follow-up. Revista de Psiquiatría y Salud Mental. 2021. Vol: 14. Núm: 3. Pág. 179-180. 10.1016/j.rpsmen.2020.10.002.
Lago, Santiago G;Papiol, Sergi;Suárez-pinilla, Paula;Ruland, Tillmann;Auyeug, Bonnie;Mikova, Olya;Kabacs, Nikolett;Arolt, Volker;Baron-cohen, Simon;Crespo-facorro, Benedicto;Bahn, Sabine;Tomasik, Jakub;Van Rees, Geertje F;Rubey, Marina;González-vioque, Emiliano;Ramsey, Jordan M;Haenisch, Frieder ;Broek, Jantine A;Vázquez-bourgon, Javier:
Exploring cellular markers of metabolic syndrome in peripheral blood mononuclear cells across the neuropsychiatric spectrum. Brain, Behavior and Immunity. 2021. Vol: 91. Pág. 673-682. 10.1016/j.bbi.2020.07.043.
Exploring cellular markers of metabolic syndrome in peripheral blood mononuclear cells across the neuropsychiatric spectrum. Brain, Behavior and Immunity. 2021. Vol: 91. Pág. 673-682. 10.1016/j.bbi.2020.07.043.
Ayesa-arriola, Rosa;Gómez-revuelta, Marcos;Tordesillas-gutiérrez, Diana;Crespo-facorro, Benedicto;Ortiz-garcía De La Foz, Víctor;Martínez-garcía, Obdulia;Setién -suero, Esther;Ramírez, María Luz;Suárez-pinilla, Paula;Mayoral-van Son, Jacqueline;Vázquez-bourgon, Javier;Juncal-ruiz, María:
Dissecting the functional outcomes of first episode schizophrenia spectrum disorders: a 10-year follow-up study in the PAFIP cohort - CORRIGENDUM. Psychological Medicine. 2020. Vol: 1. 10.1017/S0033291719003179.
Dissecting the functional outcomes of first episode schizophrenia spectrum disorders: a 10-year follow-up study in the PAFIP cohort - CORRIGENDUM. Psychological Medicine. 2020. Vol: 1. 10.1017/S0033291719003179.
Juncal -ruiz, María;Crespo-facorro, Benedicto;Riesco-davila, Laura;Vázquez-bourgon, Javier;Ortiz-garcia De La Foz, Victor;Mayoral-van Son, Jacqueline;Ayesa-arriola, Rosa;Setién-suero, Esther;Leza-Cerro, Juan Carlos;Lopez-hoyos, Marcos:
Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study. International Journal of Molecular Sciences. 2020. Vol: 21. Núm: 17. 10.3390/ijms21176106.
Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study. International Journal of Molecular Sciences. 2020. Vol: 21. Núm: 17. 10.3390/ijms21176106.
Crespo, Benedicto:
Brain grey matter abnormalities in first episode non-affective psychosis patients with suicidal behaviours: The role of neurocognitive functioning. Progress in Nneuro-Psychopharmacology & Biological Psychiatry. 2020. 10.1016/j.pnpbp.2020.109948.
Brain grey matter abnormalities in first episode non-affective psychosis patients with suicidal behaviours: The role of neurocognitive functioning. Progress in Nneuro-Psychopharmacology & Biological Psychiatry. 2020. 10.1016/j.pnpbp.2020.109948.
Vázquez-bourgon, Javier;Ibáñez-alario, Miguel;Mayoral-van Son, Jacqueline;Gómez-revuelta, Marcos;Ayesa-arriola, Rosa;Juncal-ruiz, María;Ortíz-garcía De La Foz, Victor;Crespo-facorro, Benedicto:
A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis. European Neuropsychopharmacology. 2020. Vol: 39. Pág. 46-55. 10.1016/j.euroneuro.2020.08.009.
A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis. European Neuropsychopharmacology. 2020. Vol: 39. Pág. 46-55. 10.1016/j.euroneuro.2020.08.009.
Tognin, Stefania;Dazzan, Paola;Maat, Arija;De Haan, Lieuwe;Crespo-facorro, Benedicto;Glenthoj, Birte;Lawrie, Stephen M;Mcdonald, Colm;Gruber, Oliver;Van Amelsvoort, Therese;Arango, Celso;Van Hell, Hendrika H;Kircher, Tilo ;Nelson, Barnaby;Galderisi, Silvana;Bressan, Rodrigo;Kwon, Jon S;Weiser, Mark;Mizrahi, Romina;Sachs, Gabriele;Maatz, Anke;Kahn, René;Merritt, Kate;Mcguire, Phillip ;Consortium, Psyscan ;Winter Van Rossum, Inge;Bossong, Matthijs G;Kempton, Matthew J;Modinos, Gemma;Fusar-poli, Paolo;Mechelli, Andrea:
Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Re. Schizophrenia Bulletin. 2020. Vol: 46. Núm: 2. Pág. 432-441. 10.1093/schbul/sbz067.
Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Re. Schizophrenia Bulletin. 2020. Vol: 46. Núm: 2. Pág. 432-441. 10.1093/schbul/sbz067.
Setién-suero, Esther;Suárez-pinilla, Paula ;Ferro, Adele;Tabarés-seisdedos, Rafael;Crespo-facorro, Benedicto;Ayesa-arriola, Rosa:
Childhood trauma and substance use underlying psychosis: a systematic review. European Journal of Psychotraumatology. 2020. Vol: 11. Núm: 1. 10.1080/20008198.2020.1748342.
Childhood trauma and substance use underlying psychosis: a systematic review. European Journal of Psychotraumatology. 2020. Vol: 11. Núm: 1. 10.1080/20008198.2020.1748342.
Crespo, Benedicto:
Using Machine Learning and Structural Neuroimaging to Detect First Episode Psychosis: Reconsidering the Evidence. Schizophrenia Bulletin. 2020. 10.1093/schbul/sby189.
Using Machine Learning and Structural Neuroimaging to Detect First Episode Psychosis: Reconsidering the Evidence. Schizophrenia Bulletin. 2020. 10.1093/schbul/sby189.
Labad, Javier;Montalvo, Itziar;González-rodríguez, Alexandre;García-rizo, Clemente;Crespo-facorro, Benedicto;Monreal, José Antonio;Palao, Diego:
Data of a meta-analysis on pharmacological treatment strategis for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia. Data in Brief. 2020. Vol: 31. 10.1016/j.dib.2020.105904.
Data of a meta-analysis on pharmacological treatment strategis for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia. Data in Brief. 2020. Vol: 31. 10.1016/j.dib.2020.105904.
Crespo-facorro, Benedicto:
Brief greeting and shared vision. Revista de Psiquiatría y Salud Mental. 2020. Vol: 13. Núm: 2. Pág. 53-54. 10.1016/j.rpsm.2020.04.005.
Brief greeting and shared vision. Revista de Psiquiatría y Salud Mental. 2020. Vol: 13. Núm: 2. Pág. 53-54. 10.1016/j.rpsm.2020.04.005.
Aliño-dies, María;Monfort-pañego, Manuel ;Ayesa-arriola, Rosa;Ruiz-Veguilla, Miguel;Crespo-facorro, Benedicto;Tabarés-seisdedos, Rafael;Sámchez-ortí, Joan Vicent;Correa-ghisays, Patricia;Balanzá-martínez, Vicent;Vila-francés, Joan;Selva-vera, Gabriel;Correa-estrada, Paulina;Forés-martos, Jaume;San- Martín-valenzuela, Constanza:
Grip Strength, Neurocognition, and Social Functioning in People WithType-2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizo. Frontiers in Psychology. 2020. Vol: 11. 10.3389/fpsyg.2020.525231.
Grip Strength, Neurocognition, and Social Functioning in People WithType-2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizo. Frontiers in Psychology. 2020. Vol: 11. 10.3389/fpsyg.2020.525231.
Canal-rivero, Manuel;Research Group, Pafip;Ruiz-Veguilla, Miguel;Labad, Javier;Ayesa-arriola, Rosa;Vázquez-bourgon, Javier;Mayoral-van Son, Jacqueline;Setién -suero, Esther;Ortiz-garcía De La Foz, Víctor;Crespo-facorro, Benedicto:
Predictors of weight acquisition induced by antipsychotic treatment and its relationship with age in a sample of first episode non-affective psychosis. Schizophrenia Research. 2020. Vol: 222. Pág. 462-464. 10.1016/j.schres.2020.06.011.
Predictors of weight acquisition induced by antipsychotic treatment and its relationship with age in a sample of first episode non-affective psychosis. Schizophrenia Research. 2020. Vol: 222. Pág. 462-464. 10.1016/j.schres.2020.06.011.
Crespo, Benedicto:
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3- Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzap. International Journal of Neuropsychopharmacology. 2020. 10.1093/ijnp/pyaa004.
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3- Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzap. International Journal of Neuropsychopharmacology. 2020. 10.1093/ijnp/pyaa004.
Zhang, Xuan;De Leon-Molina, Jose Alfonso;Crespo-facorro, Benedicto;Diaz, Francisco J:
Measuring individual benefits of psychiatric treatment using longitudinal binary outcomes: Application to antipsychotic benefits in non-cannabis and c. Journal of Biopharmaceutical Statistics. 2020. Vol: 30. Núm: 5. Pág. 916-940. 10.1080/10543406.2020.1765371.
Measuring individual benefits of psychiatric treatment using longitudinal binary outcomes: Application to antipsychotic benefits in non-cannabis and c. Journal of Biopharmaceutical Statistics. 2020. Vol: 30. Núm: 5. Pág. 916-940. 10.1080/10543406.2020.1765371.
García-dias, Rafael;Mcdonald, Colm;Tordesillas-gutiérrez, Diana;Cannon, Dara;Mothersill, David;Hernaus, Dennis;Morris, Derek;Setién -suero, Esther;Donohoe, Gary;Frisoni, Giovanni ;Tronchin, Giulia;Scarpazza, Cristina ;Sato, Joao;Marcelis, Machteld;Kempton, Matthew;Van Haren, Neeltje E M;Gruber, Oliver;Mcgorry, Patrick;Amminger, Paul;Mcguire, Philip;Gong, Qiyong;Kahn, René S;Baecker, Lea;Ayesa-arriola, Rosa;Van Amelsvoort, Therese;Ortiz-garcía De La Foz, Victor;Calhoun, Vonce;Cahn, Wiepke;Mechelli, Andrea;Vieira, Sandra;Pinaya, Walter H L;Corvin, Aiden;Redolfi, Alberto;Nelson, Barnaby;Crespo-facorro, Benedicto:
Neuroharmony: A new tool for harmonizing volumetric MRI data from unseen scanners. NeuroImage. 2020. Vol: 220. Núm: 6. Pág. 117-127. 10.1016/j.neuroimage.2020.117127.
Neuroharmony: A new tool for harmonizing volumetric MRI data from unseen scanners. NeuroImage. 2020. Vol: 220. Núm: 6. Pág. 117-127. 10.1016/j.neuroimage.2020.117127.
Rodríguez-sánchez, José Manuel;Setién-suero, Esther;Suárez-pinilla, Paula;Mayoral-van Son, Jacqueline;Vázquez-bourgon, Javier;Gil-lópez, Patxi;Crespo-facorro, Benedicto;Ayesa-arriola, Rosa;Grupo, Pafip:
Ten-year course of cognition in first-episode non-affective psychosis patiens:PAFIP cohort. Psychological Medicine. 2020. Pág. 1-10. 10.1017/S0033291720002408.
Ten-year course of cognition in first-episode non-affective psychosis patiens:PAFIP cohort. Psychological Medicine. 2020. Pág. 1-10. 10.1017/S0033291720002408.
Cuadrado, Antonio;Cabezas, Joaquín;Llerena, Susana;Nieves-salceda, Juan Francisco;Fortea, José Ignacio;Crespo-facorro, Benedicto;Crespo, Javier:
Prevalence of hepatitis C in patiens with non-affective psychotic disorders. Revista Española de Enfermedades Digestivas. 2020. Vol: 112. Núm: 7. Pág. 550-554. 10.17235/reed.2020.7278/2020.
Prevalence of hepatitis C in patiens with non-affective psychotic disorders. Revista Española de Enfermedades Digestivas. 2020. Vol: 112. Núm: 7. Pág. 550-554. 10.17235/reed.2020.7278/2020.
Crespo-facorro, Benedicto:
Mental health and the SARS-CoV-2 pandemic. Revista de Psiquiatría y Salud Mental. 2020. Vol: 13. Núm: 2. Pág. 55-56. 10.1016/j.rpsm.2020.04.010.
Mental health and the SARS-CoV-2 pandemic. Revista de Psiquiatría y Salud Mental. 2020. Vol: 13. Núm: 2. Pág. 55-56. 10.1016/j.rpsm.2020.04.010.
Crespo, Benedicto:
The synergetic effect of childhood trauma and recent stressful events in psychosis: associated neurocognitive dysfunction. Acta Psychiatrica Scandinavica. 2020. 10.1111/acps.13114.
The synergetic effect of childhood trauma and recent stressful events in psychosis: associated neurocognitive dysfunction. Acta Psychiatrica Scandinavica. 2020. 10.1111/acps.13114.
Crespo, Benedicto:
Needs of people with psychosis and their caregivers: «In their own voice». Revista de Psiquiatría y Salud Mental. 2020. 10.1016/j.rpsm.2019.11.002.
Needs of people with psychosis and their caregivers: «In their own voice». Revista de Psiquiatría y Salud Mental. 2020. 10.1016/j.rpsm.2019.11.002.
Ayesa-arriola, Rosa;Tordesillas-gutiérrez, Diana;Crespo-facorro, Benedicto;Ortíz-garcía De La Foz, Víctor;Setién-suero, Esther;Ramírez-bonilla, María Luz;Suárez-pinilla, Paula;Mayoral-van Son, Jacqueline;Vázquez-bourgon, Javier;Juncal-ruiz, María;Gómez-revuelta, Marcos:
Understanding sex differences in long-term outcomes after a first episode of psychosis. NPJ Schizophrenia. 2020. 10.1038/s41537-020-00120-5.
Understanding sex differences in long-term outcomes after a first episode of psychosis. NPJ Schizophrenia. 2020. 10.1038/s41537-020-00120-5.
Pardo-de Santayana, Guillermo;Vázquez-bourgon, Javier;Gómez-revuelta, Marcos;Ayesa-arriola, Rosa;Ortiz-garcía De La Foz, Victor;Crespo-facorro, Benedicto;Pelayo-terán, José María;Research Group, Pafip:
Data regarding active psychosis and functional outcome, among other clinical variables, during early phases of the illness in first-episode psychosis . Data in Brief. 2020. Vol: 30. 10.1016/j.dib.2020.105599.
Data regarding active psychosis and functional outcome, among other clinical variables, during early phases of the illness in first-episode psychosis . Data in Brief. 2020. Vol: 30. 10.1016/j.dib.2020.105599.
Labad, Javier;Montalvo, Itziar;González-rodríguez, Alexandre;García-rizo, Clemente;Crespo-facorro, Benedicto;Monreal, José Antonio;Palao, Diego:
Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-. Schizophrenia Research. 2020. Vol: 222. Pág. 88-96. 10.1016/j.schres.2020.04.031.
Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-. Schizophrenia Research. 2020. Vol: 222. Pág. 88-96. 10.1016/j.schres.2020.04.031.
Crespo-facorro, Benedicto;Newton, Richard;Such, Pedro;Nylander, Anna-greta;Madera, Jessica;Resemann, Henrike K;Worthington, Emma;O¿connor, Molly;Drane, Emma;Steeves, Sara:
The burden of disease in early schizophrenia - a systematic literature review. Journal of Current Medical Research and Opinion. 2020. Vol: 37. Núm: 1. Pág. 109-121. 10.1080/03007995.2020.1841618.
The burden of disease in early schizophrenia - a systematic literature review. Journal of Current Medical Research and Opinion. 2020. Vol: 37. Núm: 1. Pág. 109-121. 10.1080/03007995.2020.1841618.
Pardo -de Santayana, Guillermo;Vázquez-bourgon, Javier;Gómez-revuelta, Marcos ;Ayesa-arriola, Rosa;Ortiz-garcía De La Foz, Víctor;Crespo-facorro, Benedicto;Pelayo-terán, José María ;Research Group, Pafip:
Duration of active psychosis during early phases of the illness and functional outcome: The PAFIP 10-year follow-up study. Schizophrenia Research. 2020. Vol: 220. Pág. 240-247. 10.1016/j.schres.2020.03.009.
Duration of active psychosis during early phases of the illness and functional outcome: The PAFIP 10-year follow-up study. Schizophrenia Research. 2020. Vol: 220. Pág. 240-247. 10.1016/j.schres.2020.03.009.
Crespo, Benedicto:
The genetic architecture of the human cerebral cortex. Science. 2020. 10.1126/science.aay6690.
The genetic architecture of the human cerebral cortex. Science. 2020. 10.1126/science.aay6690.
López-díaz, Álvaro;Ayesa-arriola, Rosa ;Crespo-facorro, Benedicto;Ruiz-Veguilla, Miguel:
COVID-19 Infection During Pregnancy and Risk of Neurodevelopmental Disorders in Offspring: Time for Collaborative Research. Biological Psychiatry. 2020. Vol: 89. Núm: 5. Pág. e29-e30. 10.1016/j.biopsych.2020.09.011.
COVID-19 Infection During Pregnancy and Risk of Neurodevelopmental Disorders in Offspring: Time for Collaborative Research. Biological Psychiatry. 2020. Vol: 89. Núm: 5. Pág. e29-e30. 10.1016/j.biopsych.2020.09.011.
Valdés-florido, María José;López-díaz, Álvaro;Palermo-zeballos, Fernanda Jazmín;Martínez-molina, Iván;Martín-gil, Victoria Eugenia;Crespo-facorro, Benedicto;Ruiz-Veguilla, Miguel:
Reactive psychoses in the context of the COVID-19 pandemic: Clinical perspectives from a case series. Revista de Psiquiatría y Salud Mental. 2020. Vol: 13. Núm: 2. Pág. 90-94. 10.1016/j.rpsm.2020.04.009.
Reactive psychoses in the context of the COVID-19 pandemic: Clinical perspectives from a case series. Revista de Psiquiatría y Salud Mental. 2020. Vol: 13. Núm: 2. Pág. 90-94. 10.1016/j.rpsm.2020.04.009.
Crespo, Benedicto:
Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning . Brain: a journal of neurology. 2020. 10.1093/brain/awaa025.
Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning . Brain: a journal of neurology. 2020. 10.1093/brain/awaa025.
Crespo, Benedicto:
Effect of cannabis on weight and metabolism in first-episode non-affective psychosis: Results from a three-year longitudinal study. Journal of Psychopharmacology. 2019. 10.1177/0269881118822173.
Effect of cannabis on weight and metabolism in first-episode non-affective psychosis: Results from a three-year longitudinal study. Journal of Psychopharmacology. 2019. 10.1177/0269881118822173.
Crespo, Benedicto:
Verbal memory and voxel based morphometry in first episode non-affective psychosis: A process oriented approach. Neuropsychology. 2019. 10.1037/neu0000540.
Verbal memory and voxel based morphometry in first episode non-affective psychosis: A process oriented approach. Neuropsychology. 2019. 10.1037/neu0000540.
Crespo, Benedicto:
Neuroanatomical abnormalities in first-episode psychosis across independent samples: a multi-centre mega-analysis. Psychological Medicine. 2019. 10.1017/S0033291719003568.
Neuroanatomical abnormalities in first-episode psychosis across independent samples: a multi-centre mega-analysis. Psychological Medicine. 2019. 10.1017/S0033291719003568.
López-díaz, A;Fernández-gonzález, J. L. ;Lara, I. ;Crespo-facorro, Benedicto;Ruiz-Veguilla, Miguel:
The prognostic role of catatonia, hallucinations, and symptoms of schizophrenia in acute and transient psychosis. Acta Psychiatrica Scandinavica. 2019. Vol: 140. Núm: 6. Pág. 574-585. 10.1111/acps.13092.
The prognostic role of catatonia, hallucinations, and symptoms of schizophrenia in acute and transient psychosis. Acta Psychiatrica Scandinavica. 2019. Vol: 140. Núm: 6. Pág. 574-585. 10.1111/acps.13092.
Crespo, Benedicto:
Differences between psychiatric disorders in the clinical and functional effectiveness of an acute psychiatric day hospital, for acutely ill psychiatr. Revista de Psiquiatría y Salud Mental. 2019. 10.1016/j.rpsm.2019.04.001 .
Differences between psychiatric disorders in the clinical and functional effectiveness of an acute psychiatric day hospital, for acutely ill psychiatr. Revista de Psiquiatría y Salud Mental. 2019. 10.1016/j.rpsm.2019.04.001 .
Crespo, Benedicto:
Longitudinal studies of functional magnetic resonance imaging in first-episode psychosis: A systematic revie. European Psychiatry. 2019. 10.1016/j.eurpsy.2019.04.009.
Longitudinal studies of functional magnetic resonance imaging in first-episode psychosis: A systematic revie. European Psychiatry. 2019. 10.1016/j.eurpsy.2019.04.009.
Crespo, Benedicto:
Incidence of COPD in a sample of patients with psychosis: preliminary data from a 10 years longitudinal study. The European Respiratory Journal. 2019. 10.1183/13993003.congress-2019.PA4335.
Incidence of COPD in a sample of patients with psychosis: preliminary data from a 10 years longitudinal study. The European Respiratory Journal. 2019. 10.1183/13993003.congress-2019.PA4335.
Garro-Martínez, E;Lopez , Juan Francisco;Crespo, Benedicto:
Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics. Translational Psychiatry. 2019. Vol: 9. Núm: 1. 10.1038/s41398-019-0647-7.
Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics. Translational Psychiatry. 2019. Vol: 9. Núm: 1. 10.1038/s41398-019-0647-7.
Crespo, Benedicto:
Patterns of recovery course in early intervention for FIRST episode non-affective psychosis patients: The role of timing. Schizophrenia Research. 2019. 10.1016/j.schres.2019.01.032.
Patterns of recovery course in early intervention for FIRST episode non-affective psychosis patients: The role of timing. Schizophrenia Research. 2019. 10.1016/j.schres.2019.01.032.
Crespo, Benedicto:
Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo. Science Advances. 2019. 10.1126/sciadv.aau9093 .
Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo. Science Advances. 2019. 10.1126/sciadv.aau9093 .
Crespo, Benedicto:
10Kin1day: A Bottom-Up Neuroimaging Initiative. Frontiers in Neurology. 2019. 10.3389/fneur.2019.00425 .
10Kin1day: A Bottom-Up Neuroimaging Initiative. Frontiers in Neurology. 2019. 10.3389/fneur.2019.00425 .
Correa-ghisays, Patricia;Vivas-lalinde, Juliana;Conforte-molina, Candela;San-martín, Constanza;Martínez-Pérez, Carlos;Fuentes-durá, Inmaculada;Crespo-facorro, Benedicto;Tabarés-seisdedos, Rafael;Sánchez-ortí, Joan Vicent;Ayesa-arriola, Rosa;Setién-suero, Esther;Balanzá-martínez, Vicent;Selva-vera, Gabriel;Ruiz -ruiz, Juan Carlos;Vila-francés, Joan;Martínez-aran, Anabel:
Visual memory dysfunction as a neurocognitive endophenotype in bipolar disorder patients and their unaffected relatives. Evidence from a 5-year follow. Journal of Affective Disorders. 2019. Vol: 257. Pág. 31-37. 10.1016/j.jad.2019.06.059.
Visual memory dysfunction as a neurocognitive endophenotype in bipolar disorder patients and their unaffected relatives. Evidence from a 5-year follow. Journal of Affective Disorders. 2019. Vol: 257. Pág. 31-37. 10.1016/j.jad.2019.06.059.
Crespo, Benedicto:
Multimodal Integration of Brain Images for MRI-Based Diagnosis in Schizophrenia. Frontiers in Neuroscience. 2019. 10.3389/fnins.2019.01203.
Multimodal Integration of Brain Images for MRI-Based Diagnosis in Schizophrenia. Frontiers in Neuroscience. 2019. 10.3389/fnins.2019.01203.
Arango, Celso;Rico-villamoros, Fernando;Rodríguez-jiménez, Roberto;Sánchez-morla, Eva María;Segarra, Rafael;Crespo, Benedicto;Baeza, Inmaculada;Bernardo, Miguel;Cañas, Fernando;De Dios, Consuelo;Díaz-marsá, Marina;García-portilla, María Paz;Gutierrez-Rojas, Luis;Olivares, Jose Manuel:
Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain. Revista de Psiquiatría y Salud Mental. 2019. Vol: 12. Pág. 92-105.
Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain. Revista de Psiquiatría y Salud Mental. 2019. Vol: 12. Pág. 92-105.
Crespo, Benedicto:
Sex differences in gene expression related to antipsychotic induced weight gain. PLoS One. 2019. 10.1371/journal.pone.0215477.
Sex differences in gene expression related to antipsychotic induced weight gain. PLoS One. 2019. 10.1371/journal.pone.0215477.
Setién-suero, Esther;Neergaard, K. ;Ortiz-garcía De La Foz, Víctor;Suárez-pinilla, Paula;Martinez-garcía, O. ;Crespo-facorro, Benedicto;Ayesa-arriola, Rosa:
Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort. Acta Psychiatrica Scandinavica. 2019. Vol: 140. Núm: 4. Pág. 349-359. 10.1111/acps.13081.
Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort. Acta Psychiatrica Scandinavica. 2019. Vol: 140. Núm: 4. Pág. 349-359. 10.1111/acps.13081.
Crespo, Benedicto:
PMH12 THE COST OF RELAPSES MANAGEMENT IN PATIENTS SUFFERING FROM SCHIZOPHRENIA IN ITALY AND SPAIN: COMPARISON BETWEEN LURASIDONE AND QUETIAPINE XR.. Value in Health. 2019. 10.1016/j.jval.2019.09.1486.
PMH12 THE COST OF RELAPSES MANAGEMENT IN PATIENTS SUFFERING FROM SCHIZOPHRENIA IN ITALY AND SPAIN: COMPARISON BETWEEN LURASIDONE AND QUETIAPINE XR.. Value in Health. 2019. 10.1016/j.jval.2019.09.1486.
Crespo, Benedicto:
Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis. The American Journal of Psychiatry. 2019. 10.1176/appi.ajp.2018.17121363.
Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis. The American Journal of Psychiatry. 2019. 10.1176/appi.ajp.2018.17121363.
Crespo, Benedicto:
Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic Treatment. JAMA Psychiatry. 2019. 10.1001/jamapsychiatry.2019.0304.
Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic Treatment. JAMA Psychiatry. 2019. 10.1001/jamapsychiatry.2019.0304.
Crespo, Benedicto:
Time dependent expression of the blood biomarkers EIF2D and TOX in patients with schizophrenia. Brain, Behavior and Immunity. 2019. 10.1016/j.bbi.2019.05.015 .
Time dependent expression of the blood biomarkers EIF2D and TOX in patients with schizophrenia. Brain, Behavior and Immunity. 2019. 10.1016/j.bbi.2019.05.015 .
Crespo, Benedicto:
Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis. Data in Brief. 2019. 10.1016/j.dib.2019.104415.
Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis. Data in Brief. 2019. 10.1016/j.dib.2019.104415.
Crespo, Benedicto:
Altered gene expression in antipsychotic-induced weight gain. NPJ Schizophrenia. 2019. 10.1038/s41537-019-0075-y.
Altered gene expression in antipsychotic-induced weight gain. NPJ Schizophrenia. 2019. 10.1038/s41537-019-0075-y.
Gallardo-ruiz, Ruth;Crespo-facorro, Benedicto;Setién-suero, Esther;Tordesillas-gutiérrez, Diana:
Long-Term Grey Matter Changes in First Episode Psychosis: A Systematic Review. Psychiatry Investigation. 2019. Vol: 16. Núm: 5. Pág. 336-345. 10.30773/pi.2019.02.10.1.
Long-Term Grey Matter Changes in First Episode Psychosis: A Systematic Review. Psychiatry Investigation. 2019. Vol: 16. Núm: 5. Pág. 336-345. 10.30773/pi.2019.02.10.1.
Crespo, Benedicto:
Dissecting the functional outcomes of first episode schizophrenia spectrum disorders: a 10-year follow-up study in the PAFIP cohort. Psychological Medicine. 2019. 10.1017/S0033291719003179.
Dissecting the functional outcomes of first episode schizophrenia spectrum disorders: a 10-year follow-up study in the PAFIP cohort. Psychological Medicine. 2019. 10.1017/S0033291719003179.
Crespo, Benedicto:
Genetic architecture of subcortical brain structures in 38,851 individuals. Nature Genetics. 2019. 10.1038/s41588-019-0511.
Genetic architecture of subcortical brain structures in 38,851 individuals. Nature Genetics. 2019. 10.1038/s41588-019-0511.
Crespo, Benedicto:
Personality traits, theory of mind and their relationship with multiple suicide attempts in a sample of first episode psychosis patients: One-year fo. Journal of Affective Disorders. 2019. 10.1016/j.jad.2019.05.078.
Personality traits, theory of mind and their relationship with multiple suicide attempts in a sample of first episode psychosis patients: One-year fo. Journal of Affective Disorders. 2019. 10.1016/j.jad.2019.05.078.
Salagre, Estela;González-pinto, Ana;Haro, Josep María;Leza, Juan Carlos;Mckenna, Peter J.;Meana, Jose Javier;Menchón, José Manuel;Micó-Segura, Juan Antonio;Palomo, Tomás;Pazos, Ángel;Pérez, Victor;Arango, Celso;Saiz-ruiz, Jerónimo;Sanjuán, Julio;Tabarés-seisdedos, Rafael;Crespo, Benedicto;Casas, Miquel;Vilella, Elisabet;Palao, Diego;Olivares, Jose Manuel;Rodriguez-Jimenez, Roberto;Vieta, Eduard;Artigas, Francesc;Ayuso-mateos, José Luis;Bernardo, Miquel;Castro-fornieles, Josefina;Bobes, Julio;Desco, Manuel;Fañanás, Lourdes:
CIBERSAM: Ten years of collaborative translational research in mental disorders.. Revista de Psiquiatría y Salud Mental. 2019. Vol: 12. Núm: 1. Pág. 1-8. 10.1016/j.rpsm.2018.10.001.
CIBERSAM: Ten years of collaborative translational research in mental disorders.. Revista de Psiquiatría y Salud Mental. 2019. Vol: 12. Núm: 1. Pág. 1-8. 10.1016/j.rpsm.2018.10.001.
Crespo, Benedicto:
Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients.Progres. Progress in Nneuro-Psychopharmacology & Biological Psychiatry. 2019. 10.1016/j.pnpbp.2019.109677.
Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients.Progres. Progress in Nneuro-Psychopharmacology & Biological Psychiatry. 2019. 10.1016/j.pnpbp.2019.109677.
Ruderfer, Douglas M;Crespo, Benedicto;Guzman-Parra, Jose;Rivera, Margarita:
Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes. Cell. 2018. Vol: 173. Núm: 7. Pág. 1705-1715. 10.1016/j.cell.2018.05.046..
Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes. Cell. 2018. Vol: 173. Núm: 7. Pág. 1705-1715. 10.1016/j.cell.2018.05.046..
Crespo, Benedicto:
Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders. British Journal of Psychiatry. 2018.
Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders. British Journal of Psychiatry. 2018.
Crespo, Benedicto:
Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up. Schizophrenia Research. 2018.
Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up. Schizophrenia Research. 2018.
Crespo, Benedicto:
Predicting suicidal behaviour after first episode of non-affective psychosis: The role of neurocognitive functioning. European Psychiatry. 2018. 10.1016/j.eurpsy.2018.06.001.
Predicting suicidal behaviour after first episode of non-affective psychosis: The role of neurocognitive functioning. European Psychiatry. 2018. 10.1016/j.eurpsy.2018.06.001.
Crespo, Benedicto:
Understanding the Direct and Indirect Costs of a First Episode of Psychosis Program: Insights From PAFIP of Cantabria, Spain, During the First Year of. Early Intervention In Psychiatry. 2018.
Understanding the Direct and Indirect Costs of a First Episode of Psychosis Program: Insights From PAFIP of Cantabria, Spain, During the First Year of. Early Intervention In Psychiatry. 2018.
Crespo, Benedicto:
correction for sample overlap in genome-wide association studies in a polygenic pleiotropy-informed framework.. BMC Genomics. 2018.
correction for sample overlap in genome-wide association studies in a polygenic pleiotropy-informed framework.. BMC Genomics. 2018.
Crespo, Benedicto:
The right occipital lobe and poor insight in first-episode psychosis. PLoS One. 2018.
The right occipital lobe and poor insight in first-episode psychosis. PLoS One. 2018.
Crespo, Benedicto:
Duration of active psychosis and functional outcomes in first-episode non-affective psychosis. European Psychiatry. 2018.
Duration of active psychosis and functional outcomes in first-episode non-affective psychosis. European Psychiatry. 2018.
Crespo, Benedicto:
Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta An. Biological Psychiatry. 2018.
Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta An. Biological Psychiatry. 2018.
Crespo, Benedicto:
Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia. Molecular Psychiatry. 2018.
Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia. Molecular Psychiatry. 2018.
Crespo, Benedicto:
Suicidal Behavior and Personality Traits Contribute to Disability in First-episode Psychosis: A 1-Year Follow-up Study. Suicide and Life-Threatening Behavior. 2018.
Suicidal Behavior and Personality Traits Contribute to Disability in First-episode Psychosis: A 1-Year Follow-up Study. Suicide and Life-Threatening Behavior. 2018.
Crespo, Benedicto:
Insight and risk of suicidal behaviour in two first-episode psychosis cohorts: Effects of previous suicide attempts and depression. Schizophrenia Research. 2018.
Insight and risk of suicidal behaviour in two first-episode psychosis cohorts: Effects of previous suicide attempts and depression. Schizophrenia Research. 2018.
Garcia, Federico;Crespo, Benedicto:
Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm. The American Journal of Gastroenterology. 2018. 10.1038/s41395-018-0157-x.
Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm. The American Journal of Gastroenterology. 2018. 10.1038/s41395-018-0157-x.
Crespo, Benedicto:
Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks. Molecular Psychiatry. 2018. 10.1038/s41380-018-0123-4.
Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks. Molecular Psychiatry. 2018. 10.1038/s41380-018-0123-4.
Crespo, Benedicto;Agraz, Antonio Manuel:
Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR. Oncotarget. 2018. Vol: 9. Núm: 56. Pág. 30869-30882. 10.18632/oncotarget.25766.
Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR. Oncotarget. 2018. Vol: 9. Núm: 56. Pág. 30869-30882. 10.18632/oncotarget.25766.
Crespo, Benedicto:
Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium. Psychological Medicine. 2018.
Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium. Psychological Medicine. 2018.
Crespo, Benedicto:
Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature. Biological Psychiatry. 2018. 10.1016/j.biopsych.2018.10.003.
Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature. Biological Psychiatry. 2018. 10.1016/j.biopsych.2018.10.003.
Crespo, Benedicto:
The dynamic relationship between insight and suicidal behavior in first episode psychosis patients over 3-year follow-up. European Neuropsychopharmacology. 2018.
The dynamic relationship between insight and suicidal behavior in first episode psychosis patients over 3-year follow-up. European Neuropsychopharmacology. 2018.
Crespo, Benedicto;Comino-Méndez, I:
Gain-of-function mutations in DNMT3A in patients with paraganglioma. Genetics In Medicine. 2018. Vol: 20. Núm: 12. Pág. 1644-1651. 10.1038/s41436-018-0003-y.
Gain-of-function mutations in DNMT3A in patients with paraganglioma. Genetics In Medicine. 2018. Vol: 20. Núm: 12. Pág. 1644-1651. 10.1038/s41436-018-0003-y.
Crespo, Benedicto:
Evaluation of verbal inhibitory control with the Stroop Test in early episodes of psychosis with the experience of traumatic events in infancy. Revista de Neurología. 2018.
Evaluation of verbal inhibitory control with the Stroop Test in early episodes of psychosis with the experience of traumatic events in infancy. Revista de Neurología. 2018.
Crespo, Benedicto:
Plasma prolactin levels are associated with the severity of illness in drug-naive first-episode psychosis female patients. Archives of Women's Mental Health. 2018.
Plasma prolactin levels are associated with the severity of illness in drug-naive first-episode psychosis female patients. Archives of Women's Mental Health. 2018.
Crespo, Benedicto:
Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized. Schizophrenia Research. 2018.
Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized. Schizophrenia Research. 2018.
Crespo, Benedicto:
Long-term antipsychotic effectiveness in First Episode of Psychosis: a 3-year follow-up randomized clinical trial comparing aripiprazole, quetiapine a. International Journal of Neuropsychopharmacology. 2018.
Long-term antipsychotic effectiveness in First Episode of Psychosis: a 3-year follow-up randomized clinical trial comparing aripiprazole, quetiapine a. International Journal of Neuropsychopharmacology. 2018.
Crespo, Benedicto:
Blood Gene Expression Profile Predicts Response to Antipsychotics. Frontiers in Molecular Neuroscience. 2018.
Blood Gene Expression Profile Predicts Response to Antipsychotics. Frontiers in Molecular Neuroscience. 2018.
Crespo, Benedicto:
Low-density lipoprotein cholesterol and suicidal behaviour in a large sample of first-episode psychosis patients. The World Journal of Biological Psychiatry. 2018.
Low-density lipoprotein cholesterol and suicidal behaviour in a large sample of first-episode psychosis patients. The World Journal of Biological Psychiatry. 2018.
Crespo, Benedicto:
Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders. Biochemical Pharmacology. 2018.
Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders. Biochemical Pharmacology. 2018.
Antilla, V;Rivera, Margarita;Crespo, Benedicto;Guzman-Parra, Jose:
Analysis of shared heritability in common disorders of the brain. Science. 2018. Vol: 360. Núm: 6395. 10.1126/science.aap8757.
Analysis of shared heritability in common disorders of the brain. Science. 2018. Vol: 360. Núm: 6395. 10.1126/science.aap8757.
Newton, Richard;Rouleau, Alice;Nylander, Anna-greta;Loze, Jena-yves;Resemann, Henrike K.;Steeves, Sara;Crespo-facorro, Benedicto:
Diverse definitions of the early course of schizophrenia- a targeted literature review. NPJ Schizophrenia. 2018. Vol: 4. Núm: 1. 10.1038/s41537-018-0063-7.
Diverse definitions of the early course of schizophrenia- a targeted literature review. NPJ Schizophrenia. 2018. Vol: 4. Núm: 1. 10.1038/s41537-018-0063-7.
Crespo, Benedicto:
The effect of excess weight on circulating inflammatory cytokines in drug-naïve first-episode psychosis individuals. Journal of Neuroinflammation. 2018.
The effect of excess weight on circulating inflammatory cytokines in drug-naïve first-episode psychosis individuals. Journal of Neuroinflammation. 2018.
Crespo, Benedicto:
Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains. Psychological Medicine. 2017.
Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains. Psychological Medicine. 2017.
Crespo, Benedicto:
Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences. PLoS One. 2017.
Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences. PLoS One. 2017.
Crespo, Benedicto:
Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium. Acta Psychiatrica Scandinavica. 2017.
Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium. Acta Psychiatrica Scandinavica. 2017.
Crespo, Benedicto:
Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Molecular Psychiatry. 2017.
Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Molecular Psychiatry. 2017.
Crespo, Benedicto:
Tobacco smoking and its association with cognition in first episode psychosis patients.. Schizophrenia Research. 2017.
Tobacco smoking and its association with cognition in first episode psychosis patients.. Schizophrenia Research. 2017.
Lopez , Juan Francisco;Crespo, Benedicto:
Validation of schizophrenia gene expression profile in a preclinical model of maternal infection during pregnancy. Schizophrenia Research. 2017. Vol: 189. Pág. 217-218. 10.1016/j.schres.2017.02.005.
Validation of schizophrenia gene expression profile in a preclinical model of maternal infection during pregnancy. Schizophrenia Research. 2017. Vol: 189. Pág. 217-218. 10.1016/j.schres.2017.02.005.
Crespo, Benedicto:
Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-. Journal of Affective Disorders. 2017. 10.1016/j.jad.2017.03.041.
Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-. Journal of Affective Disorders. 2017. 10.1016/j.jad.2017.03.041.
Crespo, Benedicto:
Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychoti. Psychopharmacology. 2017.
Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychoti. Psychopharmacology. 2017.
Crespo, Benedicto:
When the healthcare does not follow the evidence: The case of the lack of early intervention programs for psychosis in Spain.. Revista de Psiquiatría y Salud Mental. 2017.
When the healthcare does not follow the evidence: The case of the lack of early intervention programs for psychosis in Spain.. Revista de Psiquiatría y Salud Mental. 2017.
Crespo, Benedicto:
Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffective 034e6f20e971b17fe5ad3d6d. Schizophrenia Research. 2017. 10.1016/j.schres.2017.01.046.
Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffective 034e6f20e971b17fe5ad3d6d. Schizophrenia Research. 2017. 10.1016/j.schres.2017.01.046.
Caballero-Díaz, Francisco Felix;Crespo, Benedicto:
Disability multilevel modelling in first episodes of psychosis at 3-year follow-up. Schizophrenia Research. 2017. 10.1016/j.schres.2016.12.014.
Disability multilevel modelling in first episodes of psychosis at 3-year follow-up. Schizophrenia Research. 2017. 10.1016/j.schres.2016.12.014.
Crespo, Benedicto:
Novel genetic loci associated with hippocampal volume. Nature Communications. 2017.
Novel genetic loci associated with hippocampal volume. Nature Communications. 2017.
Crespo, Benedicto:
Deep brain stimulation and treatment-resistant obsessive-compulsive disorder: A systematic review. Revista de Psiquiatría y Salud Mental. 2017.
Deep brain stimulation and treatment-resistant obsessive-compulsive disorder: A systematic review. Revista de Psiquiatría y Salud Mental. 2017.
Crespo, Benedicto:
Premorbid IQ subgroups in first episode non affective psychosis patients: Long-term sex differences in function and neurocognition. Schizophrenia Research. 2017.
Premorbid IQ subgroups in first episode non affective psychosis patients: Long-term sex differences in function and neurocognition. Schizophrenia Research. 2017.
Crespo, Benedicto:
A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics. 2017.
A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics. 2017.
Crespo-facorro, Benedicto;Ayesa -arriola, Rosa ;Ortiz-garcía De La Foz, Victor;Suárez-pinilla, Paula;Valdizan, Elsa M;Pérez-iglesias, Rocío ;Amado-señaris, José Antonio;García-unzueta, M. Teresa;Labad, Javier;Correll, Christopher:
Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffectivepsychosis: Analysis of a . Schizophrenia Research. 2017. Vol: 189. Pág. 134-141. 10.1016/j.schres.2017.01.046.
Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffectivepsychosis: Analysis of a . Schizophrenia Research. 2017. Vol: 189. Pág. 134-141. 10.1016/j.schres.2017.01.046.
Crespo, Benedicto:
Longitudinal investigation of the parietal lobe anatomy in bipolar disorder and its association with general functioning.. Psychiatry Research. 2017.
Longitudinal investigation of the parietal lobe anatomy in bipolar disorder and its association with general functioning.. Psychiatry Research. 2017.
Crespo, Benedicto:
Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non. Psychopharmacology. 2017.
Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non. Psychopharmacology. 2017.
Crespo, Benedicto:
Common and distinct structural features of schizophrenia and bipolar disorder: The European Network on Psychosis, Affective disorders and Cognitive Tr. PLoS One. 2017.
Common and distinct structural features of schizophrenia and bipolar disorder: The European Network on Psychosis, Affective disorders and Cognitive Tr. PLoS One. 2017.
Crespo, Benedicto:
Targeting recovery in first episode psychosis: The importance of neurocognition and premorbid adjustment in a 3-year longitudinal study.. Schizophrenia Research. 2017.
Targeting recovery in first episode psychosis: The importance of neurocognition and premorbid adjustment in a 3-year longitudinal study.. Schizophrenia Research. 2017.
Pilar-cuéllar, Fuencisla;Brosda, Jan;Romero, Beatriz;Crespo, Benedicto;Pazos, Ángel;Vidal, Rebeca;Díaz, Álvaro;Garro-Martínez, E;Linge, Raquel;Castro, Elena;Haberzettl, Robert;Fink, Heidrun;Bert, Bettina :
Enhanced Stress Response in 5-HT1AR Overexpressing Mice: Altered HPA Function and Hippocampal Long-Term Potentiation. ACS Chemical Neuroscience. 2017. Vol: 8. Núm: 11. Pág. 2393-2401. 10.1021/acschemneuro.7b00156.
Enhanced Stress Response in 5-HT1AR Overexpressing Mice: Altered HPA Function and Hippocampal Long-Term Potentiation. ACS Chemical Neuroscience. 2017. Vol: 8. Núm: 11. Pág. 2393-2401. 10.1021/acschemneuro.7b00156.
Crespo, Benedicto:
Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics.. Frontiers in Neuroendocrinology. 2017.
Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics.. Frontiers in Neuroendocrinology. 2017.
Crespo, Benedicto:
Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies. Systematic Reviews. 2017.
Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies. Systematic Reviews. 2017.
Morlan-coarasa, Maria Jose;Arias-loste, María Teresa;Ortíz-garcía De La Foz, Victor;Martínez-garcía, Obdulia;Alonso-martin, Carmen;Crespo, Javier;Romero-Gómez, Manuel;Fábrega, Emilio;Crespo, Benedicto:
Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year pros. Psychopharmacology. 2016. Vol: 233. Núm: 23-24. Pág. 3947-3952.
Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year pros. Psychopharmacology. 2016. Vol: 233. Núm: 23-24. Pág. 3947-3952.
Crespo, Benedicto:
Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients.. European Archives Of Psychiatry And Clinical Neuroscience. 2016.
Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients.. European Archives Of Psychiatry And Clinical Neuroscience. 2016.
Crespo, Benedicto:
Counterfactual Reasoning in Non-psychotic First-Degree Relatives of People with Schizophrenia.. Frontiers in Psychology. 2016.
Counterfactual Reasoning in Non-psychotic First-Degree Relatives of People with Schizophrenia.. Frontiers in Psychology. 2016.
Crespo, Benedicto:
Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year na. Journal of Clinical Psychiatry. 2016.
Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year na. Journal of Clinical Psychiatry. 2016.
Crespo, Benedicto:
Environmental factors linked to depression vulnerability are associated with altered cerebellar resting-state synchronization.. Scientific Reports. 2016.
Environmental factors linked to depression vulnerability are associated with altered cerebellar resting-state synchronization.. Scientific Reports. 2016.
Crespo, Benedicto:
Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nature Genetics. 2016.
Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nature Genetics. 2016.
Crespo, Benedicto:
Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept.. Nature Neuroscience. 2016.
Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept.. Nature Neuroscience. 2016.
Crespo, Benedicto:
Multi-center MRI prediction models: Predicting sex and illness course in first episode psychosis patients. NeuroImage. 2016.
Multi-center MRI prediction models: Predicting sex and illness course in first episode psychosis patients. NeuroImage. 2016.
Crespo, Benedicto:
Homocysteine and cognition: A systematic review of 111 studies. Neuroscience & Biobehavioral Reviews. 2016.
Homocysteine and cognition: A systematic review of 111 studies. Neuroscience & Biobehavioral Reviews. 2016.
Crespo, Benedicto:
The effects of tobacco smoking on age of onset of psychosis and psychotic symptoms in a first-episode psychosis population. Addiction. 2016.
The effects of tobacco smoking on age of onset of psychosis and psychotic symptoms in a first-episode psychosis population. Addiction. 2016.
Crespo, Benedicto:
Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP). European Archives Of Psychiatry And Clinical Neuroscience. 2016.
Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP). European Archives Of Psychiatry And Clinical Neuroscience. 2016.
Crespo, Benedicto:
Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia. Revista de Psiquiatría y Salud Mental. 2016.
Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia. Revista de Psiquiatría y Salud Mental. 2016.
Crespo, Benedicto:
Evidence for Genetic Overlap Between Schizophrenia and Age at First Birth in Women. JAMA Psychiatry. 2016.
Evidence for Genetic Overlap Between Schizophrenia and Age at First Birth in Women. JAMA Psychiatry. 2016.
Crespo, Benedicto:
Evidence for Trait Related Theory of Mind Impairment in First Episode Psychosis Patients and Its Relationship with Processing Speed: A 3 Year Follow-u. Frontiers in Psychology. 2016.
Evidence for Trait Related Theory of Mind Impairment in First Episode Psychosis Patients and Its Relationship with Processing Speed: A 3 Year Follow-u. Frontiers in Psychology. 2016.
Crespo, Benedicto:
Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos. Revista de Psiquiatría y Salud Mental. 2016.
Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos. Revista de Psiquiatría y Salud Mental. 2016.
Crespo, Benedicto:
Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project. Revista de Psiquiatría y Salud Mental. 2016. 10.1016/j.rpsm.2016.09.001.
Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project. Revista de Psiquiatría y Salud Mental. 2016. 10.1016/j.rpsm.2016.09.001.
Crespo, Benedicto:
Human subcortical brain asymmetries in 15,847 people worldwide reveal effects of age and sex. Brain Imaging and Behavior. 2016.
Human subcortical brain asymmetries in 15,847 people worldwide reveal effects of age and sex. Brain Imaging and Behavior. 2016.
Crespo, Benedicto:
Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review. Neurology and Therapy. 2016.
Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review. Neurology and Therapy. 2016.
Crespo, Benedicto:
Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis. International Journal of Neuropsychopharmacology. 2016.
Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis. International Journal of Neuropsychopharmacology. 2016.
Crespo, Benedicto:
Schizophrenia risk from complex variation of complement component 4.. Nature. 2016.
Schizophrenia risk from complex variation of complement component 4.. Nature. 2016.
Crespo, Benedicto:
Novel genetic loci underlying human intracranial volume identified through genome-wide association.. Nature Neuroscience. 2016.
Novel genetic loci underlying human intracranial volume identified through genome-wide association.. Nature Neuroscience. 2016.
Crespo, Benedicto:
Towards a blood-based diagnostic panel for bipolar disorder.. Brain, Behavior and Immunity. 2016.
Towards a blood-based diagnostic panel for bipolar disorder.. Brain, Behavior and Immunity. 2016.
Crespo, Benedicto:
Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms. Psychiatry Research. 2015.
Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms. Psychiatry Research. 2015.
Crespo, Benedicto:
Bipolar disorder comorbid with alcohol use disorder: focus on neurocognitive correlates.. Frontiers in Physiology. 2015.
Bipolar disorder comorbid with alcohol use disorder: focus on neurocognitive correlates.. Frontiers in Physiology. 2015.
Crespo, Benedicto:
No progression of the alterations in the cortical thickness of individuals with schizophrenia-spectrum disorder: a three-year longitudinal magnetic re. Psychological Medicine. 2015. 10.1017/S0033291715000811.
No progression of the alterations in the cortical thickness of individuals with schizophrenia-spectrum disorder: a three-year longitudinal magnetic re. Psychological Medicine. 2015. 10.1017/S0033291715000811.
Crespo, Benedicto:
Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review.. The American Journal of Psychiatry. 2015.
Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review.. The American Journal of Psychiatry. 2015.
Crespo, Benedicto:
Disability in bipolar I disorder: The 36-item World Health Organization Disability Assessment Schedule 2.0. Journal of Affective Disorders. 2015.
Disability in bipolar I disorder: The 36-item World Health Organization Disability Assessment Schedule 2.0. Journal of Affective Disorders. 2015.
Crespo, Benedicto:
Inpatient treatment for anorexia nervosa: a systematic review of randomized controlled trials.. Journal of Psychiatric Practice. 2015.
Inpatient treatment for anorexia nervosa: a systematic review of randomized controlled trials.. Journal of Psychiatric Practice. 2015.
Crespo, Benedicto:
LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nature Genetics. 2015.
LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nature Genetics. 2015.
Crespo, Benedicto:
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium.. Molecular Psychiatry. 2015.
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium.. Molecular Psychiatry. 2015.
Crespo, Benedicto:
A cross-sectional and longitudinal structural magnetic resonance imaging study of the post-central gyrus in first-episode schizophrenia patients. Psychiatry Research. 2015.
A cross-sectional and longitudinal structural magnetic resonance imaging study of the post-central gyrus in first-episode schizophrenia patients. Psychiatry Research. 2015.
Crespo, Benedicto:
Grey matter volume differences in non-affective psychosis and the effects of age of onset on grey matter volumes: A voxelwise study. Schizophrenia Research. 2015.
Grey matter volume differences in non-affective psychosis and the effects of age of onset on grey matter volumes: A voxelwise study. Schizophrenia Research. 2015.
Crespo, Benedicto:
Childhood abuse in the etiological continuum underlying psychosis from first-episode psychosis to psychotic experiences. European Psychiatry. 2015.
Childhood abuse in the etiological continuum underlying psychosis from first-episode psychosis to psychotic experiences. European Psychiatry. 2015.
Crespo, Benedicto:
A position statement of the Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA).. Maturitas. 2015.
A position statement of the Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA).. Maturitas. 2015.
Crespo, Benedicto:
Season of birth and subclinical psychosis: Systematic review and meta-analysis of new and existing data.. Psychiatry Research. 2015.
Season of birth and subclinical psychosis: Systematic review and meta-analysis of new and existing data.. Psychiatry Research. 2015.
Crespo, Benedicto:
Progressive Structural Brain Changes and NRG1 Gene Variants in First-Episode Nonaffective Psychosis.. Neuropsychobiology. 2015.
Progressive Structural Brain Changes and NRG1 Gene Variants in First-Episode Nonaffective Psychosis.. Neuropsychobiology. 2015.
Crespo, Benedicto:
Effect of DISC1 polymorphisms on the long-term course of neurocognitive deficits in non-affective psychosis. European Psychiatry. 2015.
Effect of DISC1 polymorphisms on the long-term course of neurocognitive deficits in non-affective psychosis. European Psychiatry. 2015.
Crespo, Benedicto:
Suicidal behaviour in first-episode non-affective psychosis: Specific risk periods and stage-related factors. European Neuropsychopharmacology. 2015.
Suicidal behaviour in first-episode non-affective psychosis: Specific risk periods and stage-related factors. European Neuropsychopharmacology. 2015.
Crespo, Benedicto:
Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis.. Cognitive Neuropsychiatry. 2015.
Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis.. Cognitive Neuropsychiatry. 2015.
Crespo, Benedicto:
Schizophrenia Gene Expression Profile Reverted to Normal Levels by Antipsychotics. International Journal of Neuropsychopharmacology. 2015.
Schizophrenia Gene Expression Profile Reverted to Normal Levels by Antipsychotics. International Journal of Neuropsychopharmacology. 2015.
Crespo, Benedicto:
Birth Weight and Adult IQ, but Not Anxious-Depressive Psychopathology, Are Associated with Cortical Surface Area: A Study in Twins. PLoS One. 2015.
Birth Weight and Adult IQ, but Not Anxious-Depressive Psychopathology, Are Associated with Cortical Surface Area: A Study in Twins. PLoS One. 2015.
Crespo, Benedicto:
Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset.. Translational Psychiatry. 2015.
Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset.. Translational Psychiatry. 2015.
Crespo, Benedicto:
Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review.. Current Neuropharmacology. 2015.
Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review.. Current Neuropharmacology. 2015.
Crespo, Benedicto:
Variations in Disrupted-in-Schizophrenia 1 gene modulate long-term longitudinal differences in cortical thickness in patients with a first-episode of . Brain Imaging and Behavior. 2015.
Variations in Disrupted-in-Schizophrenia 1 gene modulate long-term longitudinal differences in cortical thickness in patients with a first-episode of . Brain Imaging and Behavior. 2015.
Crespo, Benedicto:
Common genetic variants influence human subcortical brain structures. Nature. 2015.
Common genetic variants influence human subcortical brain structures. Nature. 2015.
Crespo, Benedicto:
Three-year longitudinal population-based volumetric MRI study in first-episode schizophrenia spectrum patients. Psychological Medicine. 2014. 10.1017/S0033291713002365.
Three-year longitudinal population-based volumetric MRI study in first-episode schizophrenia spectrum patients. Psychological Medicine. 2014. 10.1017/S0033291713002365.
Crespo, Benedicto:
Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis.. Psychological Medicine. 2014. 10.1017/S0033291713000330.
Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis.. Psychological Medicine. 2014. 10.1017/S0033291713000330.
Crespo, Benedicto:
Inflammatory and immune response genes have significantly altered expression in schizophrenia. Molecular Psychiatry. 2013. 10.1038/mp.2012.165.
Inflammatory and immune response genes have significantly altered expression in schizophrenia. Molecular Psychiatry. 2013. 10.1038/mp.2012.165.
Crespo, Benedicto;Mata-Pastor, Ignacio:
Global and regional cortical thinning in first-episode psychosis patients: relationships with clinical and cognitive features. . Psychological Medicine. 2011. Vol: 41. Núm: 7. Pág. 1449-1460. http://dx.doi.org/10.1017/S003329171000200X.
Global and regional cortical thinning in first-episode psychosis patients: relationships with clinical and cognitive features. . Psychological Medicine. 2011. Vol: 41. Núm: 7. Pág. 1449-1460. http://dx.doi.org/10.1017/S003329171000200X.
Mata-Pastor, Ignacio;Crespo, Benedicto:
Additive effect of NRG1 and DISC1 genes on lateral ventricle enlargement in first episode schizophrenia. NeuroImage. 2010. Vol: 53. Núm: 3. Pág. 1016-1020. http://dx.doi.org/10.1016/j.neuroimage.2009.11.010.
Additive effect of NRG1 and DISC1 genes on lateral ventricle enlargement in first episode schizophrenia. NeuroImage. 2010. Vol: 53. Núm: 3. Pág. 1016-1020. http://dx.doi.org/10.1016/j.neuroimage.2009.11.010.
Patentes
Crespo, Benedicto: METHOD FOR PREDICTING THE THERAPEUTIC RESPONSE TO ANTIPSYCHOTIC DRUGS. Número de patente:
Crespo, Benedicto: Método de monitorización de tratamiento antipsicótico. Número de patente:
Tesis dirigidas o codirigidas
(Doctorando no grabado):
Prevención de recaídas en primeros episodios psicóticos: Análisis comparativo de efectividad psicofarmacológica. Tesis Doctoral. 2020
Prevención de recaídas en primeros episodios psicóticos: Análisis comparativo de efectividad psicofarmacológica. Tesis Doctoral. 2020
(Doctorando no grabado):
Mechanisms controlling the clinical response genes to antipsychotics:role of D1 receptor-CAMP/CREB signalling in the regulation of ADAMTS2. Tesis Doctoral. 2019
Mechanisms controlling the clinical response genes to antipsychotics:role of D1 receptor-CAMP/CREB signalling in the regulation of ADAMTS2. Tesis Doctoral. 2019
Juncal-ruiz, María:
Respuesta inmunoinflamatoria sistémica en primeros episodios de psicosis. Tesis Doctoral. 2018
Respuesta inmunoinflamatoria sistémica en primeros episodios de psicosis. Tesis Doctoral. 2018
Sainz-olavarria, María Teresa:
ESTUDIO TRANSVERSAL Y LONGITUDINAL DE LA MORFOMETRÍA DE LA CORTEZA ORBITOFRONTAL EN PACIENTES CON UN PRIMER EPISODIO DE PSICOSIS NO AFECTIVA. RELACIÓN. Tesis Doctoral. 2017
ESTUDIO TRANSVERSAL Y LONGITUDINAL DE LA MORFOMETRÍA DE LA CORTEZA ORBITOFRONTAL EN PACIENTES CON UN PRIMER EPISODIO DE PSICOSIS NO AFECTIVA. RELACIÓN. Tesis Doctoral. 2017
Vazquez-bourgon, Javier:
DISC1 y Psicosis No Afectiva: Variaciones en Endofenotipos y Características Clínicas en Primeros Episodios de Psicosis. Tesis Doctoral. 2016
DISC1 y Psicosis No Afectiva: Variaciones en Endofenotipos y Características Clínicas en Primeros Episodios de Psicosis. Tesis Doctoral. 2016
Mayoral, Jacqueline :
Estudio Longitudinal de la Evolución Clínica en Pacientes que, tras un Unico Espisodio de Psicosis no Afectiva, han Alcanzado una Recuperación Complet. Tesis Doctoral. 2016
Estudio Longitudinal de la Evolución Clínica en Pacientes que, tras un Unico Espisodio de Psicosis no Afectiva, han Alcanzado una Recuperación Complet. Tesis Doctoral. 2016
Tordesillas-gutiérrez, Diana:
Diferencias en Volumen de Materia Gris en Pacientes con un Primer Episodio Psicótico y Efectos de Edad de Inicio Utilizando Morfometría Basada en Vóxe. Tesis Doctoral. 2016
Diferencias en Volumen de Materia Gris en Pacientes con un Primer Episodio Psicótico y Efectos de Edad de Inicio Utilizando Morfometría Basada en Vóxe. Tesis Doctoral. 2016
Suárez-pinilla, Paula:
CAMBIOS MORFOLOGICOS CEREBRALES EN PRIMEROS EPISODIOS DE PSICOSIS NO AFECTIVA:IMPLICACION DE VARIACIONES DE LOS POLIMORFISMOS BDNF, NRG1,CNR1. Tesis Doctoral. 2015
CAMBIOS MORFOLOGICOS CEREBRALES EN PRIMEROS EPISODIOS DE PSICOSIS NO AFECTIVA:IMPLICACION DE VARIACIONES DE LOS POLIMORFISMOS BDNF, NRG1,CNR1. Tesis Doctoral. 2015
(Doctorando no grabado):
Aplicaciones de la Imagen Médica en Psiquiatría: Un Estudio Transversal y Longitudinal en Primeros Episodios Psicóticos. Tesis Doctoral. 2014
Aplicaciones de la Imagen Médica en Psiquiatría: Un Estudio Transversal y Longitudinal en Primeros Episodios Psicóticos. Tesis Doctoral. 2014
Varela-gómez, Noemí :
Variaciones en el Gen de la Disbindina y su Relación con Sintomatología, Cognición y Neuroimagen en Pacientes con Primer Episodio de Psicosis No Afect. Tesis Doctoral. 2013
Variaciones en el Gen de la Disbindina y su Relación con Sintomatología, Cognición y Neuroimagen en Pacientes con Primer Episodio de Psicosis No Afect. Tesis Doctoral. 2013
Quintero-uribe, Luis Carlos:
Estudio Morfométrico del Lóbulo de la Insula y del Polo Temporal en Individuos con un Primer Episodio de Psicosis No Afectiva: Estudio Transversal y L. Tesis Doctoral. 2012
Estudio Morfométrico del Lóbulo de la Insula y del Polo Temporal en Individuos con un Primer Episodio de Psicosis No Afectiva: Estudio Transversal y L. Tesis Doctoral. 2012
Pelayo, José María:
Polimorfismo Va1158met del Gen Catecol-O-Metiltransferasa y Características Clínicas en Primeros Episodios de Psicosis. Tesis Doctoral. 2011
Polimorfismo Va1158met del Gen Catecol-O-Metiltransferasa y Características Clínicas en Primeros Episodios de Psicosis. Tesis Doctoral. 2011
Ayesa, Rosa:
Estudio Multidimensional de Predictores de Insight en Primeros Episodios de Psicosis. Tesis Doctoral. 2010
Estudio Multidimensional de Predictores de Insight en Primeros Episodios de Psicosis. Tesis Doctoral. 2010
(Doctorando no grabado):
Tratamiento Psicológico para la Prevención de Recaídas en Primeros Episodios de Psicosis.. Tesis Doctoral. 2009
Tratamiento Psicológico para la Prevención de Recaídas en Primeros Episodios de Psicosis.. Tesis Doctoral. 2009
Morelli, Chiara:
FENOMENOLOGIA E CORRELAZIONI CLINICHE DELL'INSIHGT NELL'ESORDIO PSICOTICO: PROGRAMMA PAFIP. Tesis Doctoral. 2009
FENOMENOLOGIA E CORRELAZIONI CLINICHE DELL'INSIHGT NELL'ESORDIO PSICOTICO: PROGRAMMA PAFIP. Tesis Doctoral. 2009
(Doctorando no grabado):
Procesos Cognitivos en Primeros Episodios de Trastornos del Espectro Esquizofrénico: Un Estudio Longitudinal.. Tesis Doctoral. 2008
Procesos Cognitivos en Primeros Episodios de Trastornos del Espectro Esquizofrénico: Un Estudio Longitudinal.. Tesis Doctoral. 2008
